Thermage FLX for Wrinkles and Loose Skin

This study is testing a device called Thermage FLX to see how safe and effective it is for improving wrinkles and loose skin on the face, neck, abdomen, and upper arms. Thermage FLX uses radiofrequency energy for non-invasive skin treatments. You might be able to join if you are between 30 and 60 years old and have mild to moderate wrinkles or loose skin in these areas. The study will look at how well the Thermage FLX treatment works after 90 days. The current recruitment status is unclear.

Study design
This is a controlled study with 164 participants, where some will receive the Thermage FLX treatment and others will not. It is a randomized, multicenter study with independent blinded evaluators.
What's involved
The study will last approximately 6 months (26 weeks). Specific details about visits or procedures are not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for at least 90 days after treatment, as this is when the primary endpoint is measured.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07187297

A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment

Recruiting
NAAges 30–60InterventionalPrevention
Bausch Health Americas, Inc.
~164 participants
Updated 2026-08-26 on ClinicalTrials.gov
What's tested:Thermage FLX

At a glance

Recruiting sites
7 of 7 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Primary Endpoint
Measured over 90 days
Wrinkle
Lax Skin
Lines Skin
7 sites across 5 states
California3
Illinois1
Massachusetts1
New York1
Texas1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Be an adult female or male, ≥30 - ≤60 years of age.

Exclusion

Participant is pregnant or breast feeding or trying to become pregnant for 3 months prior to the screening visit or during the study.
  • Primary Endpoint90 days

    Proportion of participants with any improvement on iGAIS at Day 90 as assessed by independent blinded evaluators.